Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Genetic Signatures.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: Painchek strives to Make American Aged Folk Comfortable Again
Health & Biotech
MoneyTalks: Pengana’s James McDonald reveals his top three ASX biotechs
Health & Biotech
The ASX biotechs with secured FDA clearances in 2024, and others looking likely
Health & Biotech
ASX Health Stocks: Genetic Signatures gets FDA approval; Optiscan unveils new device
News
Rise and Shine: Everything you need to know before the ASX opens
News
ASX Small Caps and IPO Weekly Wrap: The ASX walked backwards again this week as investors battle tough conditions
News
Closing Bell: Rare earths hit launches 300pc small cap moon shot, as ASX benchmark beards its bears
Health & Biotech
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
News
Market Highlights: US$200bn wiped out from Nvidia, and 5 ASX small caps to watch on Monday
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: Rare earths on the rise, and coal seam gas pilot spudded
Health & Biotech
ASX Health Stocks: Genetic Signatures jumps 20pc on FDA update, Proteomics reveals new patent in Japan
Health & Biotech
ASX Health Stocks: Sub $50m market cap Austco nabs $7.4m contract, the biggest in its history
Health & Biotech
The Ethical Investor: Why Starpharma and these ASX biotechs could stop the next infectious disease outbreak
News
Rise and Shine: Everything you need to know before the ASX opens
Experts
MoneyTalks: Zip share price could quadruple while Genetic Signatures to triple, say these brokers
Experts
